«The transplant took place last week in a 39-year-old man at Duke University Hospital in North Carolina. The man didn’t go to the hospital expecting to have a heart transplant, but it ended up saving his life.»

«Carmat got approval from the FDA last year to trial its heart in US patients with end-stage biventricular heart failure, a condition where the chambers that take in and push out blood stop working properly. Duke is one of just three transplant centers in the US participating in the trials, and the surgical team at the hospital had already undergone training for implanting the device.»

Article written by Vanessa Bates Ramirez. Photo by Carmat.



Singularity Hub